BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Business

  Kindred Bio To Announce Second Quarter 2017 Financial Results

  July 24, 2017

   · 

  1 min read
• Drug Development

  DelMar Pharma Receives Approval From China’s Human Genetic Resources Administration To Initiate Phase II Clinical Trial In Newly Diagnosed GBM

  July 24, 2017

   · 

  8 min read
• Drug Development

  Stealth Biotherapeutics Initiates Phase II/III Study of Elamipretide In Patients With Barth Syndrome

  July 24, 2017

   · 

  3 min read
• Business

  Relay Therapeutics Names Deborah Palestrant, Ph.D., Vice President Of Corporate Development And Strategy

  July 24, 2017

   · 

  2 min read
• Drug Development

  Eiger Biopharma Completes Enrollment In Phase II LIMT HDV Study Of Pegylated Interferon Lambda In Hepatitis Delta Virus Infection

  July 24, 2017

   · 

  5 min read
• Genetic Technologies Limited Receives Nasdaq Deficiency Notice

  July 24, 2017

   · 

  3 min read
• Drug Development

  Theratechnologies Announces New Findings With The Investigational Antiretroviral Ibalizumab And With EGRIFTA (Tesamorelin For Injection)

  July 24, 2017

   · 

  9 min read
• Biotech Beach

  Allegro Ophthalmics LLC Secures $10.7 Million In Private Financing

  July 24, 2017

   · 

  2 min read
• Drug Development

  NovoCure Announces A Phase Ib Clinical Trial To Evaluate The Safety Of Marizomib And Temozolomide In Combination With Optune® As Adjuvant Therapy In Patients With Glioblastoma

  July 24, 2017

   · 

  8 min read
• Fluicell Receives A New Patent Acceptance For The BioPen System

  July 24, 2017

   · 

  1 min read